Payment overview · 2025
General Payments
$23.49
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mandeep S Kohli, D.O
Allopathic & Osteopathic Physicians|General Practice · BLOOMINGDALE, IL · NPI 1447286497
Verified facts
What the public records show
CMS Open Payments records show Mandeep S Kohli, D.O received $23.49 in general payments during 2025 across 1 reported records.
Gilead Sciences, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $23.49 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.49 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 486 | 76 |
| Levothyroxine Sodium | Levothyroxine Sodium | 428 | 50 |
| Amlodipine Besylate | Amlodipine Besylate | 361 | 61 |
| Lisinopril | Lisinopril | 319 | 41 |
| Furosemide | Furosemide | 278 | 43 |
| Metformin Hcl | Metformin Hcl | 266 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 263 | 27 |
| Gabapentin | Gabapentin | 245 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 220 | 47 |
| Donepezil Hcl | Donepezil Hcl | 208 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 198 | 28 |
| Losartan Potassium | Losartan Potassium | 195 | 18 |
| Eliquis | Apixaban | 189 | 21 |
| Carvedilol | Carvedilol | 172 | 25 |
| Metoprolol Succinate | Metoprolol Succinate | 171 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 167 | 28 |
| Omeprazole | Omeprazole | 167 | 27 |
| Simvastatin | Simvastatin | 166 | 19 |
| Sertraline Hcl | Sertraline Hcl | 165 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 158 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 22 |
| Memantine Hcl | Memantine Hcl | 142 | 17 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 138 | 28 |
| Potassium Chloride | Potassium Chloride | 133 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 113 | 14 |
| Alprazolam | Alprazolam | 97 | 21 |
| Finasteride | Finasteride | 93 | 12 |
| Januvia | Sitagliptin Phosphate | 91 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 86 | suppressed |
| Prednisone | Prednisone | 86 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 86 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 83 | 25 |
| Mirtazapine | Mirtazapine | 82 | 12 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 76 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 74 | 14 |
| Trazodone Hcl | Trazodone Hcl | 74 | 17 |
| Alendronate Sodium | Alendronate Sodium | 73 | suppressed |
| Glipizide Er | Glipizide | 63 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 63 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 60 | 21 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 55 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 53 | suppressed |
| Jardiance | Empagliflozin | 53 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 47 | suppressed |
| Atenolol | Atenolol | 46 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 45 | 11 |
| Irbesartan | Irbesartan | 44 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 44 | 12 |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 43 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 42 | 21 |
| Chlorthalidone | Chlorthalidone | 42 | suppressed |
| Famotidine | Famotidine | 42 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 42 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 40 | 14 |
| Bupropion Xl | Bupropion Hcl | 39 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 39 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Torsemide | Torsemide | 37 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 36 | 11 |
| Pregabalin | Pregabalin | 36 | suppressed |
| Diazepam | Diazepam | 35 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | suppressed |
| Spironolactone | Spironolactone | 33 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Naproxen | Naproxen | 32 | suppressed |
| Bumetanide | Bumetanide | 31 | suppressed |
| Cephalexin | Cephalexin | 31 | 25 |
| Clonazepam | Clonazepam | 31 | suppressed |
| Ozempic | Semaglutide | 31 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 30 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 30 | suppressed |
| Temazepam | Temazepam | 30 | suppressed |
| Latanoprost | Latanoprost | 28 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 28 | suppressed |
| Primidone | Primidone | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 27 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 27 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Entacapone | Entacapone | 25 | suppressed |
| Olanzapine | Olanzapine | 25 | suppressed |
| Allopurinol | Allopurinol | 24 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Lorazepam | Lorazepam | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 17 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Ezetimibe | Ezetimibe | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 13 |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.49 · 1 records | Gilead Sciences, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error